Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
---|---|---|---|---|
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
US6676967 | ABBVIE | Methods for reducing flushing in individuals being treated with nicotinic acid for hyperlipidemia |
Sep, 2013
(10 years ago) | |
US7998506 | ABBVIE | Nicotinic acid compositions for treating hyperlipidemia and related methods therefor |
Sep, 2013
(10 years ago) | |
US6818229 | ABBVIE | Intermediate release nicotinic acid compositions for treating hyperlipidemia |
Sep, 2013
(10 years ago) | |
US6746691 | ABBVIE | Intermediate release nicotinic acid compositions for treating hyperlipidemia having unique biopharmaceutical characteristics |
Sep, 2013
(10 years ago) | |
US6129930 | ABBVIE | Methods and sustained release nicotinic acid compositions for treating hyperlipidemia at night |
Sep, 2013
(10 years ago) | |
US7011848 | ABBVIE | Hydrophobic component free sustained release nicotinic acid compositions for treating hyperlipidemia and related methods therefor |
Sep, 2013
(10 years ago) | |
US6406715 | ABBVIE | Intermediate release nicotinic acid compositions for treating hyperlipidemia having unique urinary metabolite profiles |
Sep, 2013
(10 years ago) | |
US6080428 | ABBVIE | Nicotinic acid compositions for treating hyperlipidemia and related methods therefor |
May, 2017
(6 years ago) | |
US6469035 | ABBVIE | Methods of pretreating hyperlipidemic individuals with a flush inhibiting agent prior to the start of single daily dose nicotinic acid therapy to reduce flushing provoked by nicotinic acid |
Mar, 2018
(6 years ago) |
Market Authorisation Date: 17 December, 2001
Treatment: A method of reducing flush in an individual being treated for a lipidemic disorder and effectively treating the lipidemic disorder; Treatment of hypertriglyceridemia by dosing once per day in the even...
Dosage: TABLET, EXTENDED RELEASE;ORAL